SCHEMBL4780315

SCHEMBL4780315

Fc1cccc(N2CC3C(C2)C3N(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.43
SLC6A3 Q01959 2/20 0.37
CCR5 P51681 1/20 0.37
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36
BACE1 P56817 1/20 0.36
SLC6A2 P23975 1/20 0.36
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
DPP7 Q9UHL4 1/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781031 0.85 GAA (0.40) TP53LMNAMAPTTSHRALDH1A1
SCHEMBL4775240 0.84 MEN1 (0.41) BPTFLMNAMAPTTSHRALDH1A1
SCHEMBL4779333 0.82 CHRM4 (0.39) DPP4DPP8DPP9DPP7
SCHEMBL4321609 0.80 GRM5 (0.42) ALDH1A1BACE1DPP4DPP8DPP9
SCHEMBL4774390 0.79 KDM4E (0.40) SLC6A3SMN1; SMN2RAB9AALDH1A1SLC6A2
SCHEMBL4780326 0.77 CHRM4 (0.40) SLC6A3SMN1; SMN2ALDH1A1SLC6A2DPP4
SCHEMBL4778369 0.76 NOTUM (0.40) TP53SMN1; SMN2LMNATSHRALDH1A1
SCHEMBL4780332 0.76 CHRM4 (0.38) SLC6A3TP53SMN1; SMN2TSHRALDH1A1
SCHEMBL4780839 0.76 SLC6A2 (0.44) LMNABACE1SLC6A2
SCHEMBL8168773 0.73 FUCA1 (0.50) ALDH1A1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed